| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9561 |
| Human Intestinal Absorption | HIA+ | 0.9965 |
| Caco-2 Permeability | Caco2+ | 0.8514 |
| P-glycoprotein Substrate | Non-substrate | 0.6704 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8810 |
| Non-inhibitor | 0.8984 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8861 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5942 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8046 |
| CYP450 2D6 Substrate | Non-substrate | 0.9026 |
| CYP450 3A4 Substrate | Substrate | 0.5552 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7355 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8668 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8241 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8403 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8369 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5978 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9736 |
| Non-inhibitor | 0.8607 |
| AMES Toxicity | Non AMES toxic | 0.9186 |
| Carcinogens | Non-carcinogens | 0.5469 |
| Fish Toxicity | High FHMT | 0.7474 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9308 |
| Honey Bee Toxicity | Low HBT | 0.5177 |
| Biodegradation | Not ready biodegradable | 0.9951 |
| Acute Oral Toxicity | III | 0.7938 |
| Carcinogenicity (Three-class) | Non-required | 0.6371 |